Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …

In the post-pandemic COVID-19 period, human activities have returned to normal and
COVID-19 cases are usually mild. However, patients with multiple myeloma (MM) present an …

COVID-19 patients typically present with lower airway disease, although involvement of
other organ systems is usually the rule. Hematological manifestations such as …

Recent data suggest a suboptimal antibody response to COVID-19 vaccination in patients
with hematological malignancies. Neutralizing antibodies (NAbs) against SARS-CoV-2 were …

Author contributions and disclosures: ET designed research, performed research, analyzed
data and wrote the paper. IPT and MAD contributed vital new reagents or analytical tools …

COVID-19, a disease caused by a novel coronavirus (SARS-CoV-2), is a major global threat
that has turned into a pandemic. Despite the emergence of multiple vaccination alternatives …

Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, caused by the
severe respiratory syndrome coronavirus 2 (SARS-CoV-2), millions of people have died …

An unprecedented global pandemic caused by a novel coronavirus named SARS-CoV-2
has created a severe healthcare threat and become one of the biggest challenges to human …

Background and aim The COVID-19 pandemic has severely affected the world's population
in the last two years. Along with non-pharmacological public health interventions, major …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
strain that causes acute respiratory illnesses known as coronavirus disease 2019 (COVID …